Repare Therapeutics CEO Lloyd Segal's 2021 pay falls 27% to $3.9M
Repare Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 1, 2022
Repare Therapeutics reported fiscal year 2021 executive compensation information on April 1, 2022.
In 2021, four executives at Repare Therapeutics received on average a compensation package of $3.4M, a 34% increase compared to previous year.
Lloyd M. Segal, Chief Executive Officer, received $3.9M in total, which decreased by 27% compared to 2020. 77% of Segal's compensation, or $3M, was in option awards. Segal also received $329K in non-equity incentive plan, $572K in salary, as well as $12K in other compensation.
Maria Koehler, Chief Medical Officer, received a compensation package of $3.7M, which increased by 220% compared to previous year. 82% of the compensation package, or $3M, was in option awards.
Michael Zinda, Chief Scientific Officer, earned $3.7M in 2021, a 230% increase compared to previous year.
Steve Forte, Chief Financial Officer, received $2.3M in 2021.